238 related articles for article (PubMed ID: 26164382)
1. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
Sun DW; An L; Wei F; Mu L; Shi XJ; Wang CL; Zhao ZW; Li TF; Lv GY
Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
Yan SR; Liu ZJ; Yu S; Bao YX
Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis.
Huang X; Zhang W; Shao Z
Cancer Med; 2019 Mar; 8(3):1148-1156. PubMed ID: 30693679
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
[TBL] [Abstract][Full Text] [Related]
12. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
[TBL] [Abstract][Full Text] [Related]
13. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.
Cen D; Chen J; Li Z; Zhao J; Cai X
PLoS One; 2017; 12(11):e0187588. PubMed ID: 29136022
[TBL] [Abstract][Full Text] [Related]
15. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
Zhang Y; Wang R; Yang X
Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
17. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
Peng F; Li H; You Q; Li H; Wu D; Jiang C; Deng G; Li Y; Li Y; Wu Y
Biomed Res Int; 2017; 2017():5019367. PubMed ID: 28386553
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.
Chen J; Zhao J; Ma R; Lin H; Liang X; Cai X
PLoS One; 2014; 9(8):e103952. PubMed ID: 25093414
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
